IP Library › Granted Patent US 8,552,068
Granted Patent B2
US 8,552,068 · App. 10/573,335 · Granted Oct 8, 2013

Compositions and methods

Inventors: Per Agvald (Bagarmossen, SE); Dag Linnarsson (Stocksund, SE); Christofer Adding (Akersberga, SE); Lars Gustafsson (Hasselby, SE); Kristofer Nilsson (Huskvarna, SE)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,552,068
App. No.
10/573,335
Granted
Oct 8, 2013
Kind
B2
Abstract

Gaseous nitric oxide (NO) can be delivered to a mammal for prophylactic or therapeutic purposes using a composition capable of delivering NO, comprising a compound capable of forming a reversible bond or association with NO. Methods for the manufacture and use of said composition are disclosed.

Claims (3)

1. A non-gaseous composition for the delivery of gaseous nitric oxide (NO), comprising a compound bonded to NO, wherein said composition contains substantially no oxygen, wherein said compound is 1,2-propanediol or 1,3-propanediol.

2. The non-gaseous composition according to claim 1 , wherein said composition is formulated as a lipid emulsion.

3. The non-gaseous composition according to claim 1 , formulated for topical, rectal, vaginal, urethral, intravesical, nasal, ocular, sublingual, buccal, oral, enteral, intravenous, intraarterial, intratracheal, intramuscular or subcutaneous administration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: AGVALD, PER; LINNARSSON, DAG; NILSSON, KRISTOFER; GUSTAFSSON, LARS E; ADDING, CHRISTOFER
To: ATTGENO AB
Reel/Frame 042569/0807 →
Priority Claims (1)
SE 0402221 · Sep 14, 2004 · national
Continuity (1)
Related Publication 20080293813A1 · Nov 27, 2008